VRCA - Wall Street Estimates - Verrica Pharmaceuticals Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 0.6491

10 %

$ 58.8 M

Market Cap

-0.35

P/E

Price Target Average

1810.34%

Revenue Forecast Estimate

170.84%

EBIT Estimate

32.35%

Net Income Estimate

84.99%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Verrica Pharmaceuticals Inc.

Wall Street analysts predict an average 1-year price target for VRCA of $12.4 , with forecasts ranging from a low of $10 to a high of $14 .

VRCA Lowest Price Target Wall Street Target

10 USD 1440.59%

VRCA Average Price Target Wall Street Target

12.4 USD 1810.34%

VRCA Highest Price Target Wall Street Target

14 USD 2056.83%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free